Cargando…

PARP1 inhibition enhances reactive oxygen species on gut microbiota

Poly(ADP‐ribose) polymerase 1 (PARP1) plays a key role in genome stability by modulating DNA‐damage responses. Activated by DNA interruptions through ultraviolet (UV) exposure, PARylation is synthesized by PARP1 and serves as a survival mechanism for cancer and metabolic diseases. Several strategies...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Yixiao, Wang, Hui, Ding, Jiyang, Zhang, Xinyi, Liu, Xiaoyu, Zhang, Shuai, Xing, Xiaorui, Kaudimba, Keneilwe Kenny, He, Muyang, Zhang, Shuang, Guo, Shanshan, Kong, Xingxing, Jin, Li, Liu, Tiemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805012/
https://www.ncbi.nlm.nih.gov/pubmed/35998296
http://dx.doi.org/10.1002/jcp.30861
_version_ 1784862245536137216
author Zhuang, Yixiao
Wang, Hui
Ding, Jiyang
Zhang, Xinyi
Liu, Xiaoyu
Zhang, Shuai
Xing, Xiaorui
Kaudimba, Keneilwe Kenny
He, Muyang
Zhang, Shuang
Guo, Shanshan
Kong, Xingxing
Jin, Li
Liu, Tiemin
author_facet Zhuang, Yixiao
Wang, Hui
Ding, Jiyang
Zhang, Xinyi
Liu, Xiaoyu
Zhang, Shuai
Xing, Xiaorui
Kaudimba, Keneilwe Kenny
He, Muyang
Zhang, Shuang
Guo, Shanshan
Kong, Xingxing
Jin, Li
Liu, Tiemin
author_sort Zhuang, Yixiao
collection PubMed
description Poly(ADP‐ribose) polymerase 1 (PARP1) plays a key role in genome stability by modulating DNA‐damage responses. Activated by DNA interruptions through ultraviolet (UV) exposure, PARylation is synthesized by PARP1 and serves as a survival mechanism for cancer and metabolic diseases. Several strategies including ROS and antimicrobial peptides (AMPs) function in host defenses, while the targeted tissue and mechanism under DNA damage are unknown. Here, we show that DNA damage induces responses specifically in the gut tissue. The knockdown of PARP1 reduces the activation of PARylation. Parp1 knockdown under DNA damage results in over‐accumulated ROS and secretion of AMPs through the regulation of Relish, a subunit of nuclear factor‐κB (NF‐κB). Double‐knockdown of Parp1 and Relish specifically in the gut inhibits AMP secretion. In conclusion, the host defense is achieved through ROS accumulation rather than the AMPs under DNA damage. In contrast, the knockdown of PARP1 exacerbates ROS accumulation to a harmful level. Under this circumstance, NF‐κb targeted AMP secretion is provoked for host defense. Microbiome and functional analysis provide evidence for the hazard of DNA damage and show variations in the metabolic pathways following Parp1 inhibition. Our findings suggest the notion that PARP1 inhibition contributes to ROS accumulation under DNA damage and its role in NF‐κb activation for host defense.
format Online
Article
Text
id pubmed-9805012
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98050122023-01-06 PARP1 inhibition enhances reactive oxygen species on gut microbiota Zhuang, Yixiao Wang, Hui Ding, Jiyang Zhang, Xinyi Liu, Xiaoyu Zhang, Shuai Xing, Xiaorui Kaudimba, Keneilwe Kenny He, Muyang Zhang, Shuang Guo, Shanshan Kong, Xingxing Jin, Li Liu, Tiemin J Cell Physiol Research Articles Poly(ADP‐ribose) polymerase 1 (PARP1) plays a key role in genome stability by modulating DNA‐damage responses. Activated by DNA interruptions through ultraviolet (UV) exposure, PARylation is synthesized by PARP1 and serves as a survival mechanism for cancer and metabolic diseases. Several strategies including ROS and antimicrobial peptides (AMPs) function in host defenses, while the targeted tissue and mechanism under DNA damage are unknown. Here, we show that DNA damage induces responses specifically in the gut tissue. The knockdown of PARP1 reduces the activation of PARylation. Parp1 knockdown under DNA damage results in over‐accumulated ROS and secretion of AMPs through the regulation of Relish, a subunit of nuclear factor‐κB (NF‐κB). Double‐knockdown of Parp1 and Relish specifically in the gut inhibits AMP secretion. In conclusion, the host defense is achieved through ROS accumulation rather than the AMPs under DNA damage. In contrast, the knockdown of PARP1 exacerbates ROS accumulation to a harmful level. Under this circumstance, NF‐κb targeted AMP secretion is provoked for host defense. Microbiome and functional analysis provide evidence for the hazard of DNA damage and show variations in the metabolic pathways following Parp1 inhibition. Our findings suggest the notion that PARP1 inhibition contributes to ROS accumulation under DNA damage and its role in NF‐κb activation for host defense. John Wiley and Sons Inc. 2022-08-22 2022-11 /pmc/articles/PMC9805012/ /pubmed/35998296 http://dx.doi.org/10.1002/jcp.30861 Text en © 2022 The Authors. Journal of Cellular Physiology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Zhuang, Yixiao
Wang, Hui
Ding, Jiyang
Zhang, Xinyi
Liu, Xiaoyu
Zhang, Shuai
Xing, Xiaorui
Kaudimba, Keneilwe Kenny
He, Muyang
Zhang, Shuang
Guo, Shanshan
Kong, Xingxing
Jin, Li
Liu, Tiemin
PARP1 inhibition enhances reactive oxygen species on gut microbiota
title PARP1 inhibition enhances reactive oxygen species on gut microbiota
title_full PARP1 inhibition enhances reactive oxygen species on gut microbiota
title_fullStr PARP1 inhibition enhances reactive oxygen species on gut microbiota
title_full_unstemmed PARP1 inhibition enhances reactive oxygen species on gut microbiota
title_short PARP1 inhibition enhances reactive oxygen species on gut microbiota
title_sort parp1 inhibition enhances reactive oxygen species on gut microbiota
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805012/
https://www.ncbi.nlm.nih.gov/pubmed/35998296
http://dx.doi.org/10.1002/jcp.30861
work_keys_str_mv AT zhuangyixiao parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT wanghui parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT dingjiyang parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT zhangxinyi parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT liuxiaoyu parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT zhangshuai parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT xingxiaorui parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT kaudimbakeneilwekenny parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT hemuyang parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT zhangshuang parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT guoshanshan parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT kongxingxing parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT jinli parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota
AT liutiemin parp1inhibitionenhancesreactiveoxygenspeciesongutmicrobiota